Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.40 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 6/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12623218 | 0.96 | PLA2G2A (0.41) | PLA2G2APLA2G4AANO1ABCG2HSD17B1 | |
| SCHEMBL29598588 | 0.87 | PLA2G2A (0.43) | PLA2G2APLA2G4AABCG2PTGS2ALDH1A1 | |
| SCHEMBL22954101 | 0.87 | PLA2G2A (0.43) | PLA2G2APLA2G4AABCG2PTGS2ALDH1A1 | |
| SCHEMBL12623241 | 0.86 | ENPP3 (0.41) | PLA2G2APLA2G4AABCG2ALDH1A1MAPT | |
| SCHEMBL23426633 | 0.85 | GPR84 (0.40) | ABCG2HSD17B1HSD17B2PGRGPR84 | |
| SCHEMBL12623253 | 0.85 | PLA2G2A (0.43) | PLA2G2APLA2G4AABCG2PTGS2ALDH1A1 | |
| SCHEMBL21131860 | 0.85 | HCRTR1 (0.38) | ANO1HSD17B1HSD17B2PGRGPR84 | |
| SCHEMBL27010125 | 0.85 | PLA2G2A (0.41) | PLA2G2APLA2G4AANO1ABCG2HSD17B1 | |
| SCHEMBL20650026 | 0.84 | ESR1 (0.39) | PLA2G2APLA2G4AHSD17B1HSD17B2GPR84 | |
| SCHEMBL24173706 | 0.84 | PLA2G2A (0.38) | PLA2G2APLA2G4AANO1HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150162536-A1 | ELECTROACTIVE MATERIALS | DU PONT (US) | 2015-06-11 | — | — | US | disclosed |
| US-20150162536-A1 | ELECTROACTIVE MATERIALS | DU PONT (US) | 2015-06-11 | — | — | US | disclosed |
| US-8992800-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-03-31 | — | — | US | disclosed |
| US-8992800-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-03-31 | — | — | US | disclosed |
| US-20130248835-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130248835-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-8460583-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-11 | — | — | US | disclosed |
| US-8460583-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-11 | — | — | US | disclosed |
| US-20130001539-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-03 | — | — | US | disclosed |
| US-20130001539-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-03 | — | — | US | disclosed |
| US-8308988-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-8308988-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-20110101310-A1 | ELECTROACTIVE MATERIALS | E.I. DU PONT DE NEMOURS AND COMPANY | 2011-05-05 | — | — | US | disclosed |
| US-20110101310-A1 | ELECTROACTIVE MATERIALS | E.I. DU PONT DE NEMOURS AND COMPANY | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150162536-A1 | ELECTROACTIVE MATERIALS | KCNN4, SCO2, SYNGR2 | PLA2G2A 2947/4885PLA2G4A 3726/4885ANO1 734/4885 |
| US-20130001539-A1 | ELECTROACTIVE MATERIALS | KCNN4, SCO2, SYNGR2 | PLA2G2A 2947/4885PLA2G4A 3726/4885ANO1 734/4885 |
| US-20110101310-A1 | ELECTROACTIVE MATERIALS | KCNN4, SCO2, SYNGR2 | PLA2G2A 2947/4885PLA2G4A 3726/4885ANO1 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.